Revolutionary Genome Sequencing Technologies The $1000 Genome (SBIR [R43/R44])
The summary for the Revolutionary Genome Sequencing Technologies The $1000 Genome (SBIR [R43/R44]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Revolutionary Genome Sequencing Technologies The $1000 Genome (SBIR [R43/R44]): Purpose. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop novel technologies that will enable extremely low-cost, high quality DNA sequencing. The goal of this initiative is to reduce the cost of sequencing a mammalian-sized genome to approximately $1000. Applicants may propose to develop full-scale sequencing systems or to investigate challenges underlying key system components. Exploration of methods other than those currently being pursued as potential $1,000 genome technologies are particularly encouraged. High-risk/high-payoff proposals are appropriate to achieve the goals of this FOA by approximately 2014. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, RFA-HG-09-011 and RFA-HG-09-012 that solicit applications under the R01 and R21 mechanisms. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 2-5 projects awarded as a result of this announcement is $2.5 million for fiscal year 2010. Future year amounts will depend on annual appropriations.
Federal Grant Title: | Revolutionary Genome Sequencing Technologies The $1000 Genome (SBIR [R43/R44]) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-HG-09-013 |
Type of Funding: | Grant |
CFDA Numbers: | 93.172 |
CFDA Descriptions: | Human Genome Research |
Current Application Deadline: | Oct 19, 2009 |
Original Application Deadline: | Oct 19, 2009 |
Posted Date: | Jul 17, 2009 |
Creation Date: | Jul 17, 2009 |
Archive Date: | Nov 19, 2009 |
Total Program Funding: | $2,500,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
- • Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
- • NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
- • Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Op...
- • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
- • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
- • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
- More Grants from the National Institutes of Health
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
- • Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...
- • NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...
- • Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...